| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $864K | — |
| Cost of Revenue | $584K | — |
| Gross Profit | $281K | — |
| R&D Expense | $1.2M | +38.7% |
| SG&A Expense | $37.1M | +438.1% |
| Operating Income | -$39.4M | -336.5% |
| Net Income | -$62.4M | -564.3% |
| EPS (Basic) | -$1.67 | -363.9% |
| EPS (Diluted) | -$1.67 | -363.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $1.0M | +13.5% |
| Current Assets | $1.4M | -42.7% |
| Total Assets | $3.6M | +34.7% |
| Current Liabilities | $10.6M | +325.2% |
| Total Liabilities | $13.9M | +119.2% |
| Stockholders' Equity | -$10.3M | -181.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.9M | -49.2% |
| Investing Cash Flow | -$1.3M | — |
| Financing Cash Flow | $5.9M | +12.4% |